🔗 Permalink

Inventor profile of:

Fred Jordan

City:

Bend, Oregon

Country:

United States

Published Applications:

Last publication date:

2025-12-25

Top Assignees for applications by Fred Jordan

The entities that hold a legal rights for patent applications filed by inventor Jordan Fred:

Deciphera Pharmaceuticals, LLC 20 Waltham, MA United States

Recent patent applications by Jordan Fred

Fred Jordan from Bend, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-25

US20250387380A1

Human necessities

AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF

#2 | 2024-11-28

US20240390345A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#3 | 2024-11-28

US20240390344A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#4 | 2024-11-28

US20240390343A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#5 | 2024-10-24

US20240350466A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#6 | 2024-06-20

US20240197696A1

Human necessities

AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF

#7 | 2024-05-09

US20240148706A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#8 | 2024-04-18

US20240122907A1

Human necessities

(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#9 | 2024-03-21

US20240091206A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#10 | 2024-02-29

US20240066013A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#11 | 2024-02-29

US20240066012A1

Human necessities

COMPOSITIONS OF 1-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL)-2-FLUOROPHEYL)-3-PHENYLUREA

#12 | 2023-12-07

US20230390258A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#13 | 2023-12-07

US20230390257A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#14 | 2023-12-07

US20230390256A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#15 | 2023-12-07

US20230390255A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#16 | 2023-08-31

US20230270728A1

Human necessities

Amorphous kinase inhibitor formulations and methods of use thereof

#17 | 2023-06-29

US20230201176A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

#18 | 2023-06-29

US20230201175A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

#19 | 2022-08-25

US20220265623A1

Human necessities

AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF

#20 | 2022-08-25

US20220265622A1

Human necessities

AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF

#21 | 2022-08-18

US20220257574A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

#22 | 2022-02-03

US20220031677A1

Human necessities

Amorphous kinase inhibitor formulations and methods of use thereof

#23 | 2021-07-01

US20210196693A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

#24 | 2021-07-01

US20210196692A1

Human necessities

Amorphous kinase inhibitor formulations and methods of use thereof

InventorID:

5121397 ⎘